Patents by Inventor Juan O. HANCKE

Juan O. HANCKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986458
    Abstract: Andrographolide 70 mg orally twice per day maintains normal health and body function in pediatric patients with Duchenne muscular dystrophy (DMD) and Becker's muscular dystrophy (BMD), and treats DMD/BMD.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: May 21, 2024
    Assignee: HP Ingredients Corp.
    Inventors: Juan O. Hancke, Enrique Brandan, Daniel Cabrera
  • Patent number: 10967035
    Abstract: A feed additive suitable for use in commercial aquaculture, made from whole dried seaweed powder supplemented with 2.5 percent (w/w) andrographolide, increases feed conversion ratio (the ratio of weight gain to weight of feed used) and growth rate, while reducing vulnerability to water-borne marine pathogens such as Piscirickettsia salmonis and white-spot syndrome virus.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: April 6, 2021
    Assignee: HP Ingredients Corp.
    Inventors: Annie Eng, Juan O. Hancke
  • Patent number: 10722492
    Abstract: Andrographolide 240 mg/day orally is the first treatment shown to significantly benefit progressive forms of Multiple Sclerosis in human patients.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: July 28, 2020
    Assignee: Inno Bioscience, LLC
    Inventor: Juan O. Hancke
  • Publication number: 20190083458
    Abstract: Andrographolide 240 mg/day orally is the first treatment shown to significantly benefit progressive forms of Multiple Sclerosis in human patients.
    Type: Application
    Filed: June 8, 2017
    Publication date: March 21, 2019
    Applicant: InnoBiosciences, LLC
    Inventor: Juan O. HANCKE